Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
EV/Core EBITDA

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   EV/Core EBITDA(x) 5.707.186.7912.651.60

What is the latest EV/Core EBITDA ratio of NATH BIOGENES (INDIA) ?

The latest EV/Core EBITDA ratio of NATH BIOGENES (INDIA) is 5.70 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20255.70
Mar20247.18
Mar20236.79
Mar202212.65
Mar20131.60

How is EV/Core EBITDA of NATH BIOGENES (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2025 5.7
-20.61
Mar2024 7.18
5.74
Mar2023 6.79
-46.32
Mar2022 12.65
690.63
Mar2013 1.6 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare EV/Core EBITDA ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹268.9 Cr -10.4% -15.2% -26.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,899.4 Cr 0.6% -3% -23% Stock Analytics
KAVERI SEED COMPANY ₹5,031.3 Cr -1.7% -6.7% 5.9% Stock Analytics
VENKYS (INDIA) ₹1,874.2 Cr -2% -12.5% -23.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,070.1 Cr -2.4% -14.5% -35.7% Stock Analytics
INDO US BIOTECH ₹257.4 Cr 2.2% -1.8% -49.9% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-10.4%

-15.2%

-26.4%

SENSEX

0%

2.7%

6.8%


You may also like the below Video Courses